Jason A. Rosenzweig to Yersinia pestis
This is a "connection" page, showing publications Jason A. Rosenzweig has written about Yersinia pestis.
Connection Strength
3.389
-
Rosenzweig JA, Hendrix EK, Chopra AK. Plague vaccines: new developments in an ongoing search. Appl Microbiol Biotechnol. 2021 Jun; 105(12):4931-4941.
Score: 0.773
-
Lawal A, Kirtley ML, van Lier CJ, Erova TE, Kozlova EV, Sha J, Chopra AK, Rosenzweig JA. The effects of modeled microgravity on growth kinetics, antibiotic susceptibility, cold growth, and the virulence potential of a Yersinia pestis ymoA-deficient mutant and its isogenic parental strain. Astrobiology. 2013 Sep; 13(9):821-32.
Score: 0.450
-
Rosenzweig JA, Chopra AK. The effect of low shear force on the virulence potential of Yersinia pestis: new aspects that space-like growth conditions and the final frontier can teach us about a formidable pathogen. Front Cell Infect Microbiol. 2012; 2:107.
Score: 0.419
-
Rosenzweig JA, Brackman SM, Kirtley ML, Sha J, Erova TE, Yeager LA, Peterson JW, Xu ZQ, Chopra AK. Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin. Antimicrob Agents Chemother. 2011 Nov; 55(11):5034-42.
Score: 0.391
-
Rosenzweig JA, Jejelowo O, Sha J, Erova TE, Brackman SM, Kirtley ML, van Lier CJ, Chopra AK. Progress on plague vaccine development. Appl Microbiol Biotechnol. 2011 Jul; 91(2):265-86.
Score: 0.386
-
Lawal A, Jejelowo OA, Rosenzweig JA. The effects of low-shear mechanical stress on Yersinia pestis virulence. Astrobiology. 2010 Nov; 10(9):881-8.
Score: 0.370
-
Rosenzweig JA, Weltman G, Plano GV, Schesser K. Modulation of yersinia type three secretion system by the S1 domain of polynucleotide phosphorylase. J Biol Chem. 2005 Jan 07; 280(1):156-63.
Score: 0.244
-
Sha J, Kirtley ML, van Lier CJ, Wang S, Erova TE, Kozlova EV, Cao A, Cong Y, Fitts EC, Rosenzweig JA, Chopra AK. Deletion of the Braun lipoprotein-encoding gene and altering the function of lipopolysaccharide attenuate the plague bacterium. Infect Immun. 2013 Mar; 81(3):815-28.
Score: 0.107
-
Erova TE, Rosenzweig JA, Sha J, Suarez G, Sierra JC, Kirtley ML, van Lier CJ, Telepnev MV, Motin VL, Chopra AK. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine. Clin Vaccine Immunol. 2013 Feb; 20(2):227-38.
Score: 0.107
-
Sha J, Rosenzweig JA, Kirtley ML, van Lier CJ, Fitts EC, Kozlova EV, Erova TE, Tiner BL, Chopra AK. A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague. Microb Pathog. 2013 Feb; 55:39-50.
Score: 0.106
-
Andersson JA, Fitts EC, Kirtley ML, Ponnusamy D, Peniche AG, Dann SM, Motin VL, Chauhan S, Rosenzweig JA, Sha J, Chopra AK. New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria. Antimicrob Agents Chemother. 2016 06; 60(6):3717-29.
Score: 0.034